We are Sorry, This Page doesn't Exist
Merck announces FDA approval of Keytruda for certain bladder cancer patients
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Myriad Genetics"s stock surges after FDA approval of diagnostic test for pancreatic cancer
Share of Myriad Genetics Inc. shot up 8.3% in premarket trading Monday, after the molecular diagnostics company said its BRACAnalysis CDx was approved by the Food and Drug Administration as a companion test to iden.....»»
Roche announces FDA approval of Tecentriq with chemotherapy for lung cancer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Clovis Oncology ovarian cancer drug receives fast-tracked FDA approval
Clovis Oncology won the fast-tracked verdict it hoped for on Friday when the U.S. Food and Drug Administration approved marketing the company's ovarian cancer drug rucaparib to treat a broader range of patients. The FDA approved the Boulder-based .....»»
Namaste Announces Record-Breaking Quarterly Sales of $5.6M Representing a 195% Quarter-Over-Quarter Increase and Over 1,600 Medical Cannabis Patients Acquired To-Date Through NamasteMD
VANCOUVER, British Columbia, April 30, 2018 (GLOBE NEWSWIRE) -- Namaste Technologies Inc. ("Namaste" or the "Company") (CSE:N), (FRA.....»»
Bristol-Myers Posts Data on Empliciti, China Approves Opdivo
Bristol-Myers (BMY) announces positive results on oncology drug Empliciti. The company's blockbuster drug, Opdivo, was also approved in China for lung cancer. Br.....»»
Atara Biotherapeutics Announces Second Quarter 2018 Financial Results and Recent Operational Progress
SOUTH SAN FRANCISCO, Calif., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (NASDAQ:ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, aut.....»»
Qiagen receives FDA approval to expand use of EGFR test in lung cancer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Why Merrimack Pharma Is Terminating Its Midstage Lung Cancer Study
Merrimack Pharmaceuticals shares dropped early on Friday after the company announced that it would be terminating its midstage SHERLOC study in patients with non-small cell lung cancer......»»
Zai Lab announces approval of Zejula for patients with relapsed ovarian cancer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Epizyme to File NDA for Tazemetostat in Follicular Lymphoma
Epizyme (EPZM) announces that the company has identified a path to submission for accelerated approval of tazemetostat for patients with relapsed and/or .....»»
Exelixis stock up more than 4% after FDA drug approval
Shares of Exelixis Inc. rose more than 4% in the extended session Monday after the Alameda, Calif., biotech company said the U.S. Food and Drug Administration has approved its Cabometix drug for patients with certain types of advanced liver cancer.....»»
Qiagen gets Japan approval for EGFR lung cancer test as companion diagnostic
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Vision Marine Technologies announces contract with Limestone Boat Company
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Heron"s stock rises after FDA approval of surgical medicine
Shares of Heron Therapeutics Inc. gained 3.0% in trading on Thursday after the company said the Food and Drug Administration had approved its non-opioid anesthetic for use in some surgical patients. The drug, Zynrelef, is expected to bec.....»»
Genprex in-licenses gene therapy technologies for lung cancer treatment
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
California-based Getlabs picks Philadelphia for East Coast launch, passes the "grandmother test"
The company sends phlebotomists into the homes of patients who need to give blood samples for lab testing......»»
NEUROONE BEGINS 2021 BY HITTING FIRST PERFORMANCE MILESTONE AND CLOSES LUCRATIVE PRIVATE PLACEMENT
It's been an eventful year for NeuroOne Medical Technologies Corp (OTCQB: NMTC), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders. read more.....»»
NovoCure surges 65% to all-time high on upbeat review of its lung cancer treatment trial
"Pending regulatory approval, the recommended protocol adjustments could accelerate trial completion by more than a year," its CEO said. In this phot.....»»